| Current evidence for vitamin D in intestinal function and disease M Hassanshahi, PH Anderson, CL Sylvester, AM Stringer Experimental Biology and Medicine 244 (12), 1040-1052, 2019 | 17 | 2019 |
| Therapeutic Potential of a Novel Vitamin D3 Oxime Analogue, VD1-6, with CYP24A1 Enzyme Inhibitory Activity and Negligible Vitamin D Receptor Binding AK Alshabrawy, Y Cui, C Sylvester, D Yang, ES Petito, KR Barratt, ... Biomolecules 12 (7), 960, 2022 | 8 | 2022 |
| New therapeutic strategies for combatting gastrointestinal toxicity CL Sylvester, PH Anderson, AM Stringer Current Opinion in Supportive and Palliative Care 14 (2), 142-152, 2020 | 5 | 2020 |
| Therapeutic inhibition vs. intestinal deletion of CYP24A1 and its effects on chemotherapy-induced gastrointestinal mucositis CL Sylvester, PH Anderson, AM Stringer ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 16, 111-111, 2020 | | 2020 |
| Inhibition of vitamin D catabolism and its effects on chemotherapy-induced gastrointestinal mucositis C Sylvester, P Anderson, A Stringer NEUROGASTROENTEROLOGY AND MOTILITY 32, 2020 | | 2020 |
| Intestinal-Specific Cyp24a1 Deletion Induces Toll-Like Receptor-4 Expression and Reduces Chemotherapy-Induced Intestinal Injury in Mice PCK Thianhlun, CL Sylvester, HR Wardill, PH Anderson, AM Stringer Available at SSRN 4809711, 0 | | |
| POSTER LISTING M Carr, A Davidson, B Josephs, NW Kam, C Lim, E Lim, C Seet-Lee, ... | | |
Paul H. AndersonUniversity of South Australia在 unisa.edu.au 的电子邮件经过验证
Paul H. AndersonUniversity of South Australia在 unisa.edu.au 的电子邮件经过验证
Andrea StringerAssociate Professor of Medical Sciences, University of South Australia在 unisa.edu.au 的电子邮件经过验证